Insider · CIK 0002103579

Heineman Thomas Charles

Reports to the SEC for 1 company · SAN DIEGO, CA

Transactions

Companies

Filings

CIK

0002103579

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ONCYONCOLYTICS BIOTECH INC · Stock OptionA Award	Chief Medical Officer	AAward	+260K sh	—	—	260,000
2026-02-12	ONCYONCOLYTICS BIOTECH INCP Purchase	Chief Medical Officer	PPurchase	+12.1K sh	$0.83	+$10K	282,818

C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325

SAN DIEGO, CA, 92121